| 3 months clinical follow-up | n = 40 | % |
| Readmission for ACS | 4 | 10% |
| Arrythmias | 2 | 5% |
| Heart failure | 1 | 2.5% |
| Stroke/TIA | 0 | 0 |
| New Myocardial Infarction | 0 | 0 |
| Cardiac mortality | 0 | 0 |